-+ 0.00%
-+ 0.00%
-+ 0.00%

*Eupraxia Pharmaceuticals to Use Net Proceeds From Offering Primarily for Continued Advancement of Its Product Pipeline >EPRX.T

Dow Jones·09/23/2025 02:56:00

Please log in to view news